Subscribe to RSS
DOI: 10.1055/a-2795-7008
Translational Insights into Liposomal Drug Delivery: Recent Advances, Therapeutic Applications, and Clinical Trials
Authors

Abstract
Liposomes are artificially constructed, phospholipid-based vesicular systems that have emerged as vital components in pharmaceutical nanotechnology and advanced drug delivery. Their flexible bilayered structure enables the encapsulation of a broad spectrum of therapeutic agents, enhancing drug stability and bioavailability. Since their discovery, liposomes have been widely explored as efficient drug carriers and diagnostic tools due to their superior capacity to deliver active pharmaceutical ingredients precisely to target sites. Their inherent advantages including high biocompatibility, the enhanced permeability and retention effect for passive tumor targeting, customizable surface modification for improved targeting efficiency, and enhanced physicochemical stability collectively position them as promising nanocarriers for cancer therapy and other biomedical applications. Liposomes, as synthetic nanoscale vesicles, offer significant promise for immunotherapeutic interventions due to their capability to codeliver antigens and adjuvants while modulating immune cell behavior. Specialized formulations such as immunoliposomes, virosomes, and other immunostimulatory complexes engineered with specific ligands or immune active moieties exhibit unique structural and functional profiles that enhance anticancer immune responses. Furthermore, liposomes facilitate targeted cargo delivery to immune cells, influencing their phenotype and functional activity. This review presents an integrated overview of liposomal composition, structural attributes, mechanisms of drug delivery, therapeutic applications, and clinical progress. The use of liposomes in delivering small molecules, macromolecules, and nucleic acids has demonstrated significant advancements, underscoring their expanding role in modern therapeutics. Overall, this article provides a comprehensive and up-to-date examination of liposome technology and its clinical translational potential.
Keywords
liposomes - drug delivery systems - fabrication and formulation - purification and characterization, - anticancer therapeutics, - targeted drug deliveryPublication History
Received: 09 December 2025
Accepted after revision: 22 January 2026
Article published online:
25 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules 2022; 27 (04)
- 2 Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles – from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 2021; 15 (11) 16982-17015
- 3 Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater 2021; 6 (12) 1078-1094
- 4 Thi TTH, Suys EJA, Lee JS. et al. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines (Basel) 2021; 9 (04) 359
- 5 Wang S, Chen Y, Guo J, Huang Q. Liposomes for tumor targeted therapy: a review. Int J Mol Sci 2023; 24 (03) 2643
- 6 Mehta M, Bui TA, Yang X. et al. Lipid-based nanoparticles for drug/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au 2023; 3 (06) 600-619
- 7 Andra VVSNL, Pammi SVN, Bhatraju LVKP, Ruddaraju LK. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. Bionanoscience 2022; 12 (01) 274-291
- 8 Gatto MS, Johnson MP, Najahi-Missaoui W. Targeted liposomal drug delivery: overview of the current applications and challenges. Life (Basel) 2024; 14 (06) 672
- 9 Pande S. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artif Cells Nanomed Biotechnol 2023; 51 (01) 428-440
- 10 Sobol Ż, Chiczewski R, Wątróbska-Świetlikowska D. Advances in liposomal drug delivery: multidirectional perspectives on overcoming biological barriers. Pharmaceutics 2025; 17 (07) 885
- 11 Basak S, Das TK. Liposome-based drug delivery systems: from laboratory research to industrial production—instruments and challenges. ChemEngineering 2025; 9 (03) 56
- 12 Mohamed M, Abu Lila AS, Shimizu T. et al. PEGylated liposomes: immunological responses. Sci Technol Adv Mater 2019; 20 (01) 710-724
- 13 Izadiyan Z, Misran M, Kalantari K. et al. Advancements in liposomal nanomedicines: innovative formulations, therapeutic applications, and future directions in precision medicine. Int J Nanomedicine 2025; 20: 1213-1262
- 14 Lee Y, Thompson DH. Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9 2017;
- 15 Lu H, Zhang S, Wang J, Chen Q. A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr 2021; 8: 783831
- 16 Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines 2014; 2 (06) 159-182
- 17 Shaikh Hamid MS, Hatwar PR, Bakal RL, Kohale NB. A comprehensive review on liposomes: as a novel drug delivery system. GSC Biol Pharm Sci 2024; 27 (01) 199-210
- 18 Huang J, Zhang Y, Jin H. et al. Recent advances in phototherapy-based nanomedicine of lymphoma. Mater Today Bio 2025; 33: 102047
- 19 Abboud HA, Zelkó R, Kazsoki A. A systematic review of liposomal nanofibrous scaffolds as a drug delivery system: a decade of progress in controlled release and therapeutic efficacy. Drug Deliv 2025; 32 (01) 2445259
- 20 Rahim MA, Zahran HA, Jaffar HM. et al. Liposomal encapsulation in food systems: a review of formulation, processing, and applications. Food Sci Nutr 2025; 13 (08) e70587
- 21 Zizzari A, Bianco M, Carbone L. et al. Continuous-flow production of injectable liposomes via a microfluidic approach. Materials 2017; 10 (12) 1411
- 22 Mukai H, Ogawa K, Kato N, Kawakami S. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics. Drug Metab Pharmacokinet 2022; 44: 100450
- 23 Patel R, Morker K, Purohit D. Development and analytical characterization of liposomes: a comprehensive approach. Int J Pharm Sci 2025; 3: 2005-2021
- 24 Alfutaimani AS, Alharbi NK, Alahmari AS, Alqabbani AA, Aldayel AM. Exploring the landscape of lipid nanoparticles (LNPs): a comprehensive review of LNPs types and biological sources of lipids. Int J Pharm X 2024; 8: 100305
- 25 Chen J, Hu S, Sun M. et al. Recent advances and clinical translation of liposomal delivery systems in cancer therapy. Eur J Pharm Sci 2024; 193: 106688
- 26 Francesca S, Domenico T, Edouard C. et al. Influence of drug/lipid interaction on the entrapment efficiency of isoniazid in liposomes for antitubercular therapy: a multi-faced investigation. Colloids Surf B Biointerfaces 2021; 208: 112054
- 27 Rebollo R, Oyoun F, Corvis Y. et al. Microfluidic manufacturing of liposomes: development and optimization by design of experiment and machine learning. ACS Appl Mater Interfaces 2025; 14 (35) 39736-39745
- 28 Viegas C, Patrício AB, Prata JM. et al. Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics 2023; 15 (06) 1593
- 29 Eugster R, Meneghetti M. Liposomes: bridging the gap from lab to pharmaceuticals — unresolved challenges in parenteral formulations. Eur J Pharm Biopharm 2025; 75: 101875
- 30 Tretiakova DS, Vodovozova EL. Liposomes as adjuvants and vaccine delivery systems. Biochem (Mosc) Suppl Ser A Membr Cell Biol 2022; 16 (01) 1-20
- 31 Jourdain M-A, Eyer J. Recent advances in liposomes and peptide-based therapeutics for glioblastoma treatment. J Control Release 2024; 376: 732-752
- 32 Singh A, Srivastava A, Gupta A. Liposomal drug delivery system – a review. J Appl Pharm Sci Res 2020; 3 (03) 07-10
- 33 Ruano M, Mateos-Maroto A, Ortega F. et al. Fabrication of robust capsules by sequential assembly of polyelectrolytes onto charged liposomes. Langmuir 2021; 37 (20) 6189-6200
- 34 Vázquez-Quesada A, Schofield MM, Tsortos A. et al. Hydrodynamics of quartz-crystal-microbalance DNA sensors based on liposome amplifiers. Phys Rev App 2020; 13 (06) 064059
- 35 Liu Z, Chen J, Xu M. et al. Programmable lipid nanoparticles for precision drug delivery: a four-domain model perspective 2024
- 36 Simões S, Filipe A, Faneca H. et al. Cationic liposomes for gene delivery. Expert Opin Drug Deliv 2005; 2: 237-254
- 37 Javed A, Mandal P, Khan I. et al. Liposomal drug delivery for neurological disorders: advances and challenges. Cent Nerv Syst Agents Med Chem 2025; 25 (03) 245-260
- 38 Karaz S, Senses E. Liposomes under shear: structure, dynamics, and drug delivery applications. Adv NanoBiomed Res 2023; 3: 2200101
- 39 Koning GA, Eggermont AM, Lindner LH, ten Hagen TL. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 2010; 27 (08) 1750-1754
- 40 Schlich M, Musazzi UM, Campani V. et al. Design and development of topical liposomal formulations in a regulatory perspective. Drug Deliv Transl Res 2022; 12 (08) 1811-1828
- 41 Souto EB, Dias-Ferreira J, López-Machado A. et al. Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents. Pharmaceutics 2019; 11 (09) 460
- 42 Wang Y, Grainger D. Regulatory considerations specific to liposome drug development as complex drug products. Front Drug Deliv 2022; 2: 901281
- 43 Ferreira M, Ogren M, Dias JNR. et al. Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance. Molecules 2021; 26 (07) 2047
- 44 Lombardo D, Kiselev MA. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics 2022; 14 (03) 543
- 45 Aslan M, Ertaş N, Demir MK. Storage stability, heat stability, controlled release and antifungal activity of liposomes as alternative fungal preservation agents. Food Biosci 2023; 51: 102281
- 46 Binaymotlagh R, Hajareh Haghighi F, Chronopoulou L, Palocci C. Liposome–hydrogel composites for controlled drug delivery applications. Gels 2024; 10: 284
- 47 Verma S, Utreja P. Vesicular nanocarrier based treatment of skin fungal infections: potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci 2019; 14 (02) 117-129
- 48 Amin M, Seynhaeve ALB, Sharifi M, Falahati M, ten Hagen TLM. Liposomal drug delivery systems for cancer therapy: the rotterdam experience. Pharmaceutics 2022; 14 (10) 2165
- 49 Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics 2017; 9 (02) 12
- 50 Agrawal SS, Baliga V, Londhe VY. Liposomal formulations: a recent update. Pharmaceutics 2025; 17 (01) 36
- 51 Balazs DA, Godbey W. Liposomes for use in gene delivery. J Drug Deliv 2011; 2011: 326497
- 52 Ilić-Stojanović S, Cakić S, Nikolić N, Petrović S. Innovative and patented liposome-based drug carriers. Processes 2024; 12 (09) 1970
- 53 Chelliah R, Rubab M, Vijayalakshmi S, Karuvelan M, Barathikannan K, Oh D-H. Liposomes for drug delivery: classification, therapeutic applications, and limitations. Next Nanotechnol 2025; 8: 100209
- 54 van Alem CMA, Metselaar JM, van Kooten C, Rotmans JI. Recent advances in liposomal-based anti-inflammatory therapy. Pharmaceutics 2021; 13 (07) 1004
- 55 Jiang L, Gu Y, Du Y, Tang X, Wu X, Liu J. Engineering exosomes endowed with targeted delivery of triptolide for malignant melanoma therapy. ACS Appl Mater Interfaces 2021; 13 (36) 42411-42428
- 56 Wang C, Cheng X, Su Y. et al. Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs. Int J Nanomedicine 2015; 10: 3533-3545
- 57 Vladkova TG, Smani Y, Martinov BL, Gospodinova DN. Recent progress in terrestrial biota derived antibacterial agents for medical applications. Molecules 2024; 29 (20) 4889
- 58 Lee W, Im HJ. Theranostics based on liposome: looking back and forward. Nucl Med Mol Imaging 2019; 53 (04) 242-246
- 59 Wang Y, Grainger DW. Lyophilized liposome-based parenteral drug development: reviewing complex product design strategies and current regulatory environments. Adv Drug Deliv Rev 2019; 151–152: 56-71
- 60 Domingues C, Jarak I, Veiga F, Dourado M, Figueiras A. Pediatric drug development: reviewing challenges and opportunities by tracking innovative therapies. Pharmaceutics 2023; 15 (10) 2431
- 61 Parveen S, Gupta P, Kumar S, Banerjee M. Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics. Med Drug Discov 2023; 20: 100165
- 62 Stone NR, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome(®)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs 2016; 76 (04) 485-500
- 63 Ferreira-Silva M, Faria-Silva C, Viana Baptista P, Fernandes E, Ramos Fernandes A, Corvo ML. Liposomal nanosystems in rheumatoid arthritis. Pharmaceutics 2021; 13 (04) 454
- 64 Ghosh S, Carter KA, Lovell JF. Liposomal formulations of photosensitizers. Biomaterials 2019; 218: 119341
- 65 Agrawal SS, Baliga V, Londhe VY. Liposomal formulations: a recent update. Pharmaceutics 2024; 17 (01) 36
- 66 Nsairat H, Khater D, Sayed U. et al. Liposomes: structure, composition, types, and clinical applications. Heliyon 2022; 8 (05) e09394
- 67 Liu GW, Guzman EB, Menon N, Langer RS. Lipid nanoparticles for nucleic acid delivery to endothelial cells. Pharm Res 2023; 40 (01) 3-25
- 68 Billard A, Pourchet L, Malaise S, Alcouffe P, Montembault A, Ladavière C. Liposome-loaded chitosan physical hydrogel: toward a promising delayed-release biosystem. Carbohydr Polym 2015; 115: 651-657
- 69 Olusanya TOB, Haj Ahmad RR, Ibegbu DM. et al. Liposomal drug delivery systems and anticancer drugs. Molecules 2018; 23 (04) 907
- 70 Kumar S, Saxena J, Srivastava VK. et al. The interplay of oxidative stress and ROS scavenging: antioxidants as a therapeutic potential in sepsis. Vaccines (Basel) 2022; 10 (10) 1575
- 71 Lamichhane N, Udayakumar TS, D’Souza WD. et al. Liposomes: clinical applications and potential for image-guided drug delivery. Molecules 2018; 23 (02) 288
- 72 Zhang X, Tu S, Tian J. et al. Liposome-based nanoparticle delivery systems for lung diseases: opportunities and challenges. Int J Nanomedicine 2025; 20: 12485-12509
- 73 Aguirre-Cruz G, León-López A, Cruz-Gómez V, Jiménez-Alvarado R, Aguirre-Álvarez G. Collagen hydrolysates for skin protection: oral administration and topical formulation. Antioxidants 2020; 9: 181
- 74 Boafo GF, Magar KT, Ekpo MD, Qian W, Tan S, Chen C. The role of cryoprotective agents in liposome stabilization and preservation. Int J Mol Sci 2022; 23 (20) 12487
- 75 Rao M, Peachman KK, Alving CR. Liposome formulations as adjuvants for vaccines. Curr Top Microbiol Immunol 2021; 433: 1-28
- 76 Shadab A, Ansari AF. Adaptive nanocarriers: a new era in transdermal delivery with transferosomes. J Drug Delivery Ther 2025; 15 (11) 72-84
- 77 Dutt Y, Pandey RP, Dutt M. et al. Liposomes and phytosomes: nanocarrier systems and their applications for the delivery of phytoconstituents. Coord Chem Rev 2023; 491: 215251
- 78 Chelliah R, Momna R, Vijayalakshmi S, Karuvelan M, Kannan B, Oh D-H. Liposomes for drug delivery: classification, therapeutic applications, and limitations. Next Nanotechnol 2025; 8: 100209
- 79 Umar M, Sherazi TA, Talha M. et al. Nanoliposome-based drug delivery systems for the treatment of diabetes mellitus: a review. RSC Adv 2025; 15: 49119-49143
- 80 Đorđević S, Gonzalez MM, Conejos-Sánchez I. et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res 2022; 12 (03) 500-525
- 81 Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol 2015; 6: 286
- 82 Miao G, He Y, Lai K. et al. Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients. J Control Release 2023; 363: 12-26
- 83 Nwabuife JC, Pant AM, Govender T. Liposomal delivery systems and their applications against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Adv Drug Deliv Rev 2021; 178: 113861
- 84 Fulton MD, Najahi-Missaoui W. Liposomes in cancer therapy: how did we start and where are we now. Int J Mol Sci 2023; 24 (07) 6615
- 85 Wang J, Chen R, Xie Y, Qin X, Zhou Y, Xu C. Endo/lysosomal-escapable lipid nanoparticle platforms for enhancing mRNA delivery in cancer therapy. Pharmaceutics 2025; 17 (07) 803
- 86 Nikolova MP, Kumar EM, Chavali MS. Updates on responsive drug delivery based on liposome vehicles for cancer treatment. Pharmaceutics 2022; 14 (10) 2195
- 87 Rachamala HK. Translational advances in lipid nanoparticle drug delivery systems for cancer therapy: current status and future horizons. Pharmaceutics 2025; 17 (10) 1315
- 88 Saraswathi TS, Mothilal M, Bukke SPN, Thalluri C, Chettupalli AK. Recent advances in potential drug nanocarriers for CNS disorders: a review. Biomed Eng Online 2025; 24 (01) 137
- 89 Eugster R, Luciani P. Liposomes: bridging the gap from lab to pharmaceuticals. Curr Opin Colloid Interface Sci 2025; 75: 101875
